Last SFr.108.00 CHF
Change Today -1.00 / -0.92%
Volume 276.7K
ATLN On Other Exchanges
Symbol
Exchange
OTC US
Xetra
SIX Swiss Ex
OTC US
As of 11:43 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carl B. Feldbaum Esq.

Director and Chairman of Nominating & Governance Committee, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 56 board members in 7 different organizations across 4 different industries.

See Board Relationships
70SFr.168,826

Background*

Mr. Carl B. Feldbaum, Esq. serves as the President Emeritus at Biotechnology Industry Organization. Mr. Feldbaum came to Washington D.C. in 1973 as an Assistant Special Prosecutor for the Watergate special prosecution force to work with Archibald Cox to investigate and prosecute the Watergate scandal. He was also the President and Founder of the Palomar Corporation. Mr. Feldbaum served as an Assistant to the Secretary of Energy, and served as the Inspector General for ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123

Switzerland

Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Director
Director and Chairman of Nominating & Governance Committee
Director
Chairman
Director
2005-N/A
Former Director, Member of Compensation Committee and Member of Governance and Nominating Committee
2007-Present
Director and Member of Nominating & Corporate Governance Committee

Education*

Bachelor's Degree
Princeton University
JD
University of Pennsylvania - Law School
LLB
University of Pennsylvania - Law School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationSFr.56,925
Total Calculated CompensationSFr.168,826
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.108.00 CHF -1.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Marc M.P. de Garidel Chairman, Chief Executive Officer and Member of Strategic Committee
Ipsen S.A.
€1.4M
Jörg-Thomas Dierks Chief Executive Officer
Meda AB
kr2.1M
Timo Lappalainen M.Sc. (Ind. Eng.)Chairman of the Executive Management Board, Chief Executive Officer and President
Orion Oyj
€1.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.